Mezzion Pharma Co.Ltd (140410) — Cash Flow Reinvestment Rate

Latest as of September 2023: 2.33x

Mezzion Pharma Co.Ltd (140410) has a Cash Flow Reinvestment Rate of 2.33x as of September 2023, reinvesting ₩11.01 Billion (capex ₩5.46 Billion plus investments ₩-5.55 Billion) from operating cash flow of ₩4.73 Billion. Explore 140410 capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

2.33x
(Capex + Investments) / Operating CF

Total Reinvested

₩11.01 Billion
Capex + Investments

Operating Cash Flow

₩4.73 Billion
KRW

Capital Expenditures

₩5.46 Billion
KRW

Mezzion Pharma Co.Ltd Cash Flow Reinvestment Rate (2012–2015)

Historical reinvestment intensity for Mezzion Pharma Co.Ltd across 2 annual periods. Also explore Mezzion Pharma Co.Ltd assets under control for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Mezzion Pharma Co.Ltd (2012–2015)

Year-by-year capital reinvestment analysis for Mezzion Pharma Co.Ltd. For live market cap and broader valuation context, see Mezzion Pharma Co.Ltd market cap and net worth.

Year Reinvestment Rate Total Reinvested (KRW) Operating CF Capex YoY Change
2015 0.55x ₩983.20 Million ₩1.77 Billion ₩564.10 Million ▲ +77.0%
2012 0.31x ₩983.20 Million ₩3.14 Billion ₩564.10 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow